
What Happened?
Shares of business intelligence platform Domo (NASDAQ: DOMO) jumped 8.4% in the morning session after it announced a joint solution with Regional One Health Solutions to integrate Artificial Intelligence into healthcare operations.
The new solution, built on Amazon Web Services (AWS), is designed to help healthcare organizations embed AI directly into clinical, financial, and operational workflows, moving beyond traditional data dashboards.
This development places Domo at the intersection of two high-growth sectors: healthcare technology and artificial intelligence, likely fueling investor optimism about the company's future prospects and potential for new revenue streams.
Is now the time to buy Domo? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Domo’s shares are extremely volatile and have had 68 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The previous big move we wrote about was about 22 hours ago when the stock dropped 9.2% on the news that software stocks declined for a second consecutive session, extending the profit-taking that began earlier in the week.
The broader market was essentially flat when the correction started the previous day: the S&P 500 was unchanged, the Nasdaq barely moved, confirming this was sector-level digestion, not broad risk-off selling.
To understand the pullback, you need to understand the depth of what preceded it. In a 48-hour span in early February 2026, roughly $285 billion was wiped from software stock valuations after Anthropic's Claude Cowork platform raised genuine fears that AI agents could make per-seat SaaS licensing obsolete, a moment the market called the "SaaSpocalypse." Over the following months, the IGV fell more than a third from its September 2025 peak, hitting a 52-week low on April 10. At that point, approximately 75% of software stocks were screening as technically oversold.
The recovery was fast. The IGV rose 21% in May alone, its best monthly performance since October 2001, and gained approximately 40-44% from the April low. By June 2, it had crossed back into positive YTD territory for the first time, sitting approximately 11% below its all-time peak. Strong results from Snowflake and MongoDB gave the rebound fundamental cover. But the final push was options- and retail-driven, not institutional. On June 2, call volumes in the IGV outpaced puts, and Oracle options saw billions in premium trade with a three-to-one call-to-put ratio.
That is the key to understanding why portfolio managers are likely not defending these levels. Most institutional managers who cut software exposure during the SaaSpocalypse would have faced a recovery that moved faster than their mandates allowed for rebuilding positions. Rather than chase, watching for a pullback and a better entry might be better. For those already positioned from the early recovery, the rational move was to let names reset before adding.
Domo is down 51.9% since the beginning of the year, and at $4.00 per share, it is trading 78% below its 52-week high of $18.20 from September 2025. Investors who bought $1,000 worth of Domo’s shares 5 years ago would now be looking at only $59.49.
WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.
This is what the early days of Palantir looked like before it became a $437 billion giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.


